Mesenchymal Stem (Stromal) Cells for Treatment of ARDS: A Phase 1 Clinical Trial

BACKGROUND: There is no effective pharmacotherapy for the acute respiratory distress syndrome (ARDS), and mortality remains high. Preclinical studies support the efficacy of mesenchymal stem (stromal) cells (MSCs) in the treatment of lung injury. The aim of this phase one clinical trial was to test...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Respir Med
Main Authors: Wilson, Jennifer G., Liu, Kathleen D., Zhuo, Hanjing, Caballero, Lizette, McMillan, Melanie, Fang, Xiaohui, Cosgrove, Katherine, Vojnik, Rosemary, Calfee, Carolyn S., Lee, Jae-Woo, Rogers, Angela J., Levitt, Joseph, Wiener-Kronish, Jeanine, Bajwa, Ednan K., Leavitt, Andrew, McKenna, David, Thompson, B. Taylor, Matthay, Michael A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4297579/
https://ncbi.nlm.nih.gov/pubmed/25529339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-2600(14)70291-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados